1. Mutagen-mediated enhancement of HIV-1 replication in persistently infected cells
- Author
-
Cecilio López-Galíndez, Esteban Domingo, Víctor Toledano, Ana Grande-Pérez, Ramon Lorenzo-Redondo, Isabel Olivares, Carmen Sánchez-Jiménez, Mónica Gutiérrez-Rivas, Ana Isabel de Ávila Lucas, Fundación para la Investigación y la Prevención del Sida en España, Red Española de Investigación en SIDA, Ministerio de Economía y Competitividad (España), and Fundación Ramón Areces
- Subjects
HIV Infections ,HIV-1 persistent cell line ,Biology ,Virus Replication ,Deoxycytidine ,Virus ,Cell Line ,Pyrimidine analogue ,chemistry.chemical_compound ,Mutation Rate ,Virology ,medicine ,Viral replication ,Humans ,Lethal mutagenesis ,5-hydroxy-2′-deoxycytidine (5-OHdC) ,Infectivity ,Nucleoside analogue ,5-fluorouracil (5-FU) ,Gemcitabine ,2′,2′-difluoro-2′-deoxycytidine (gemcitabine) ,chemistry ,Cell culture ,Mutation ,HIV-1 ,RNA, Viral ,Nucleoside analogs ,Fluorouracil ,Mutagens ,medicine.drug - Abstract
Lethal mutagenesis, a new antiviral strategy to extinguish virus through elevated mutation rates, was explored in H61-D cells an HIV-1 persistently infected lymphoid cell line. Three mutagenic agents: 5-hydroxy-2 '-deoxycytidine (5-OHdC), 5-fluorouracil (5-FU) and 2,2 '-difluoro-2 '-deoxycytidine (gemcitabine) were used. After 54 passages, treatments with 5-FU and gemcitabine reduced virus infectivity, p24 and RT activity. Treatment with the pyrimidine analog 5-OHdC resulted in increases of p24 production, RT activity and infectivity. Rise in viral replication by 5-OHdC during HIV-1 persistence is in contrast with its inhibitory effect in acute infections. Viral replication enhancement by 5-OHdC was associated with an increase in intracellular HIV-1 RNA mutations. Mechanisms of HIV-1 replication enhancement by 5-OHdC are unknown but some potential factors are discussed. Increase of HIV-1 replication by 5-OHdC cautions against the use, without previous analyses, of mutagenic nucleoside analogs for AIDS treatment. © 2011 Elsevier Inc., Fundacion para la Investigacion y Prevencion del SIDA en España (FIPSE); Red Temática Cooperativa de Investigación en SIDA (Red de grupos 173) of the Fondo de Investigaciones Sanitarias de la Seguridad Social; MICINN; Fundación Ramón Areces
- Published
- 2012
- Full Text
- View/download PDF